The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

TILS TIZIANA LIFE SCIENCES PLC ORD 3P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 29-Sep-2017 TILS Interim Results for Six Months Ended 30 June 2017 RNS +0.89% Up
07:00 06-Sep-2017 TILS A Proprietary Oral Formulation of Foralumab RNS -3.75% Down
11:07 31-Aug-2017 TILS Grant of options - Director's dealing RNS -0.30% Down
07:00 16-Aug-2017 TILS Conversion of outstanding loan notes RNS +1.61% Up
07:00 28-Jul-2017 TILS Publication of Research Article on Foralumab RNS +1.17% Up
07:00 19-Jul-2017 TILS Initiation of a Phase IIa Clinical Trial RNS -4.60% Down
07:00 12-Jul-2017 TILS Proposed changes to CLNs and Warrant Terms RNS -0.07% Down
11:21 29-Jun-2017 TILS Result of AGM RNS -0.58% Down
07:00 12-Jun-2017 TILS Appointment of Dr Kunwar Shailubhai as CEO RNS -10.82% Down
10:02 08-Jun-2017 TILS NOTIFICATION OF MAJOR INTEREST IN SHARES RNS -15.78% Down
08:14 08-Jun-2017 TILS Bcl-3 pre-clinical update and Director's dealing RNS -15.78% Down
07:00 01-Jun-2017 TILS 2016 Annual Report and Accounts and notice of AGM RNS +0.72% Up
07:00 23-May-2017 TILS Financial Results for Year Ended 31 December 2016 RNS +2.14% Up
07:14 24-Apr-2017 TILS Announces Approval of a Phase II Clinical Trial RNS +14.84% Up
07:00 21-Apr-2017 TILS Announces Publication of Milciclib Clinical Trial RNS +18.33% Up
07:00 24-Mar-2017 TILS Exercise of Warrants & Issue of Equity RNS -9.17% Down
07:00 14-Mar-2017 TILS Arun Sanyal appointed to Scientific Advisory Board RNS +13.24% Up
07:00 16-Jan-2017 TILS Warrant Expiry - Reminder RNS +0.58% Up
07:00 03-Jan-2017 TILS Tiziana Life Sciences in-licenses NI-1201 RNS +3.95% Up
07:00 16-Nov-2016 TILS New Data with Foralumab RNS +14.09% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 18 South Street, Mayfair, London, W1K 1DG, United Kingdom
Company website http://www.tizianalifes...
Market cap(in millions)* £ 143.67
Listing/Admission to trading 24 Apr 2014
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
24-Oct-17
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 1,500
SEDOL BKWNZY5
ISIN number GB00BKWNZY55



TIZIANA LIFE SC share news analysis (TILS)